Cancer antigen 15-3 (CA15-3) in addition to carcinoembryonic antigen (CEA) along with cancer antigen 125 (CA125) are extensively used in the clinical practice of breast cancer as serum tumor markers. This evidence concerns the gene CEACAM5 and breast cancer.